Ingevity Research and Development Expenses 2014-2024 | NGVT

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Ingevity research and development expenses from 2014 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

Ingevity Research and Development Expenses 2014-2024 | NGVT

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Ingevity research and development expenses from 2014 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

Related Stocks
Company Name	Market Cap
Linde (LIN)	$211.4B
Sherwin-Williams (SHW)	$94.1B
Ecolab (ECL)	$69.2B
PPG Industries (PPG)	$28.1B
Novozymes (NVZMY)	$26.5B
International Flavors & Fragrances (IFF)	$22.7B
Axalta Coating Systems (AXTA)	$8.5B
Celanese (CE)	$7.9B
CSW Industrials (CSWI)	$7B
Element Solutions (ESI)	$6.7B
Balchem (BCPC)	$5.8B
Arcadium Lithium (ALTM)	$5.6B
NewMarket (NEU)	$5.1B
Valvoline (VVV)	$5B
Nissan Chemical (NNCHY)	$4.5B
H B Fuller (FUL)	$4B
Ashland (ASH)	$3.6B
Sensient Technologies (SXT)	$3.2B
Quaker Houghton (KWR)	$2.9B
Hawkins (HWKN)	$2.6B
Minerals Technologies (MTX)	$2.5B
Perimeter Solutions, SA (PRM)	$1.9B
Orbia Advance, S.A.B De C.V (MXCHY)	$1.7B
ELEMENTIS (ELMTY)	$1.3B
DAQO New Energy (DQ)	$1.2B
Orion S.A (OEC)	$1B
Huabao Holdings (HUIHY)	$943M
Westlake Chemical Partners LP (WLKP)	$796M
AdvanSix (ASIX)	$778M
Green Plains (GPRE)	$682M